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Background: Amyloid-β plaques are a defining characteristic of Alzheimer Disease. However, Amyloid-β deposition
is also found in other forms of dementia and in non-pathological contexts. Amyloid-β deposition is variable among
vertebrate species and the evolutionary emergence of the amyloidogenic property is currently unknown.
Evolutionary persistence of a pathological peptide sequence may depend on the functions of the precursor gene,
conservation or mutation of nucleotides or peptide domains within the precursor gene, or a species-specific
physiological environment.
Results: In this study, we asked when amyloidogenic Amyloid-β first arose using phylogenetic trees constructed for
the Amyloid-β Precursor Protein gene family and by modeling the potential for Amyloid-β aggregation across
species in silico. We collected the most comprehensive set of sequences for the Amyloid-β Precursor Protein family
using an automated, iterative meta-database search and constructed a highly resolved phylogeny. The analysis
revealed that the ancestral gene for invertebrate and vertebrate Amyloid-β Precursor Protein gene families arose
around metazoic speciation during the Ediacaran period. Synapomorphic frequencies found domain-specific
conservation of sequence. Analyses of aggregation potential showed that potentially amyloidogenic sequences are
a ubiquitous feature of vertebrate Amyloid-β Precursor Protein but are also found in echinoderm, nematode, and
cephalochordate, and hymenoptera species homologues.
Conclusions: The Amyloid-β Precursor Protein gene is ancient and highly conserved. The amyloid forming
Amyloid-β domains may have been present in early deuterostomes, but more recent mutations appear to have
resulted in potentially unrelated amyoid forming sequences. Our results further highlight that the species-specific
physiological environment is as critical to Amyloid-β formation as the peptide sequence.
Keywords: Amyloid, Alzheimer disease, Phylogenetics, In silico, Aggregation, Maximum parsimony, Bayesian
inferenceBackground
The Amyloid-β Precursor Protein (AβPP, APP) has been
intensively studied due to its role in the generation of
pathogenic cortical plaques in Alzheimer Disease [1]. It
belongs to a gene family with deep evolutionary origins
and is a member of a highly conserved protein family of
type-1 transmembrane proteins [2-4]. The AβPP family
consists of up to three homologues in vertebrate species:
AβPP, amyloid precursor like protein 1 (APLP-1), and
amyloid precursor like protein 2 (APLP-2). Invertebrate
species genomes encode a single homologue referred to* Correspondence: neil.sarkar@uvm.edu
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distribution, and reproduction in any mediumas either amyloid precursor like 1 protein (APL-1) or
AβPP-like 1 protein (APPL-1). Vertebrates and flat-
worms exhibit ubiquitous expression of at least one
member of the AβPP family, while fruit flies express
APPL-1 only in neurons. In all species, AβPP proteins
are cleaved into multiple peptides and fragments by a
series of proteases, but only vertebrate AβPP contains
the sequence coding the pathological Amyloid-β (Aβ)
peptide fragment.
The β-fold intrinsic to amyloid formation is a com-
monly observed biochemical property [5-7]. Amyloid
formation is observed in non-pathological contexts from
an efficient steric mechanism for storage of small pep-
tide hormones to rudimentary forms of biological
compartmentalization [5,8]. The neuropathological
changes observed in the brains of patients with
Alzheimer Disease led to the formation of the Amyloidtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of Aβ fibrils and low-order intracellular Aβ oligomers in
the disruption of neuronal function, distortion of neural
architecture, and induction of inflammation [1].
Mutations in the AβPP sequence and in associated
proteases have been independently associated with fa-
milial early onset Alzheimer Disease characterized by
rapidly progressive dementia and heavy Aβ plaque bur-
den [9]. Recently, a protective mutation in AβPP redu-
cing the formation of Aβ was identified [10]. However,
>95% of sporadic Alzheimer Disease exhibits no muta-
tion in the AβPP gene sequence. Further, deposition of
Aβ is not limited to Alzheimer Disease. Aβ plaques have
been observed in vascular dementias, Lewy body demen-
tia, and Parkinson Disease with dementia, as well as in
the brains of aged individuals without any cognitive defi-
cits [11-14]. Together, these studies indicate that while
the sequence of Aβ can contribute to the progression
and severity of disease factors regulating the production
by proteolysis and the degradation and clearance of Aβ,
it also plays a critical role in generation of Aβ pathology.
Beyond the eponymous production of Aβ, AβPP pro-
cessing produces other active peptides with functions
ranging from hemostatic modulators to trophic factors
to pro-apoptotic proteins [15-18]. There is a substantial
body of knowledge focusing on the neural impacts of
AβPP and Aβ. However, this family of proteins is also
widely expressed in peripheral tissues of vertebrate spe-
cies including skin, skeletal muscle, leukocytes, platelets,
intestinal epithelia, pancreas, and adipose tissue. The
function and regulation of non-neuronal AβPP are not
fully understood [19-26].
The AβPP family is variably essential for viability
among species. Experimental data show that the N-
terminus of APL-1 is necessary for progression through
molting stages by nematodes [27]. The C-terminus of at
least one member of the AβPP family is necessary for
viability in early parturition of knockout mouse models
[28-30]. Drosophila models without APPL-1 show subtle
neuronal patterning defects but remain viable and able
to reproduce [31]. Zebrafish knockout models have im-
paired body development and synaptogenesis [32,33].
Each of these models can be rescued by expression of
truncated portions of AβPPs, indicating that absences of
different domains are responsible for the observed le-
thality or defects in each model. Thus, the persistence of
this protein family appears domain-dependent among
species despite high evolutionary conservation of the
entire gene.
The major conserved regions found in AβPP family
proteins include two ectoplasmic domains (E1 and E2),
which contain extracellular matrix and divalent cation
binding regions and a growth-factor-like domain
(GFLD), and the cytoplasmic region (E3) that contains abasolateral sorting signal (BLS) and an NPXY internal-
ization sequence (YENPTY) (Figure 1). The correspond-
ing nucleic acids coding the domains are termed D1, D2,
and D3, respectively. Other important conserved do-
mains include a Kunitz-protease inhibitor (KPI) domain
found only in vertebrate AβPP and APLP-2, as well as
the βA4 region that gives rise to Aβ in certain vertebrate
species. Interestingly, it has been demonstrated that
the corresponding region of APPL-1 in Drosophila
melanogaster can form amyloid deposits when co-
expressed in high levels with the Drosophila β-secretase
[34]. Similar to the conservation of the E1, E2, and E3
domains, the βA4 region and corresponding regions may
have arisen from a common ancestral domain [35]. It is
not known when the amyloidogenic trait first appeared
in this gene family nor why species with nearly identical
Aβ sequences do not develop Aβ deposits.
Previous phylogenetic studies showed that this ancient
protein family has been widely distributed among multi-
cellular eukaryotes since at least the divergence of
protostomia and deuterostomia [36]. These studies and
corresponding conclusions are based on at most ten se-
quences that were trimmed and concatenated, focusing
solely on the major conserved domains (D1, D2, and D3
only). Use of trimmed sequences does yield cleaner se-
quence alignments and better branch supports on the
phylogenetic tree, but ignores potentially valuable evolu-
tionary data encoded in adjoining regions. For the AβPP
gene family in particular, the omission of Aβ from the
analyses occludes an understanding of the evolution of
the pathological eponymous domain. Despite wide distri-
bution of the AβPP family across species, it is not know
when amyloidogenic Aβ peptides first evolved. This
study uses the full complement of available molecular
sequence data to provide an in silico model of the evolu-
tionary history of this essential gene family and the ori-
gin of the Aβ peptide.
Results
Phylogenetics of AβPP gene family
Amino acid and nucleotide sequences were collected
using an automated, iterative search method from Entrez
Protein (GenPept) and Entrez Nucleotide (GenBank)
(see Methods and Additional file 1: Table S1). Character
matrices were generated in Mesquite 2.75 and aligned
using Muscle 3.8.31) and the longest sequence for each
species’ homologue(s) was retained [37,38]. Amino acid
and nucleotide trees were generated under maximum
parsimony using TNT 1.1 and Bayesian inference using
MrBayes 3.2 [39,40].
The overall topology of the nucleotide and amino acid
trees is similar among trees generated by maximum
parsimony (Figure 2a and b) and Bayesian inference
(Additional file 1: Figure S1a and b). Branch support
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Figure 1 Conserved Regions of the Amyloid-β Precursor Protein Gene Family. Schematic representations of the five members of the
Amyloid-β Precursor Protein (AβPP) gene family show multiple conserved domains: N-Terminal Signal peptide (NTS), growth factor-like domain
(GFLD), heparin binding domain (Hep), copper binding domain (Cu), zinc binding domain (Zn), an acidic amino-acid rich region (D/E), collagen
binding domain (Col), a basolateral sorting signal (BLS), and a clathrin-binding internalization signal domain (YENPTY). Certain members of the
gene family also contain a Kunitz-protease inhibitor domain (KPI), the amyloid-β forming region (βA4), an OX-2 domain (diagonal hashmarks), a
putative collagen binding domain (horizontal white hashmarks), and/or a glutamine and serine-rich region (Q/S).
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file 1: Figure S1 and support for the maximum parsi-
mony analyses are found in Additional file 1: Figure S2.
The presence of an AβPP-like sequence in hydra
(Hydra magnipapillata) and sea anemone (Nematostella
vectensis) genomes suggests that the ancestral gene arose
around metazoic divergence in the Ediacaran period, be-
tween 630–540 million years ago (Mya). No related se-
quences from single-celled organisms were found. A
single member of the gene family has persisted across
invertebrate species with a major divergence around the
evolution of arthropods during the Cambrian period giv-
ing rise to APPL-1 (~500 Mya). Two gene duplication
events occurred during the evolution of vertebrate spe-
cies. Our search recovered a single AβPP-like gene for
the cephalochordate lancelet (Branchiostomidae floridae)
genome that was more closely related to mollusks and
cnidarians than vertebrate sequences. The cartilaginous
ray (Narke japonica) genome contains a single AβPP
gene with high homology to human AβPP. The results
indicate that AβPP and APLP-2 genes are present in the
zebrafish (Danio rerio) but only AβPP was recovered for
other members of class Osteichthyes (Takifugu rubripes,
Tetraodon fluviatilis, and Perca flavescens). The majorityof tetrapod genomes in this study contained all three
members of the vertebrate AβPP gene family. Sequences
for all three genes were found for Xenopus species, but
APLP-1 sequences were not found for any members of
class Aves or Reptilia.
Within the gene family, the nucleotide sequence
phylogenetic trees (Figure 2a) indicate that AβPP and
APLP-2 are more closely related than APLP-1 and
APLP-2. Furthermore, the placement in the nucleotide
phylogenetic tree suggests that APLP-1 may be the ori-
ginal vertebrate sequence. However, placement of the
AβPP branch on the nucleotide tree is weakly supported
under both maximum parsimony (47% resampling sup-
port, 12% relative Bremer; see Additional file 1: Figure
S2a, b) and Bayesian inference (60% posterior probabil-
ity; see Additional file 1: Figure S1a). In the amino acid
sequence phylogenetic trees, APLP-1 and APLP-2
are more closely related and AβPP appears to be the
original vertebrate peptide (Figure 2b). This arrangement
has higher support for the placement of AβPP (65%
resampling support, 100% relative Bremer support
[maximum parsimony] Additional file 1: Figure S2c, d;
100% posterior probability [Bayesian inference]; Additional
file 1: Figure S1b).
Figure 2 Phylogenetic Relationships of 103 members of the
Amyloid-β Precursor Protein Gene Family. Shown are:
(a) Phylogram showing the evolutionary relationships among the
nucleotide sequences of the AβPP gene family; (b) Phylogram for
the corresponding protein sequences. Trees were generated by
maximum parsimony methods. Scale bars indicate character
changes contributing to branch lengths.
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The variability in the essential nature of the AβPP gene
family can be observed by analyzing the evolutionary
differences between related genes and shared residues
according to specific functional domains. This was ac-
complished using synapomorphy frequency histograms.
A synapomorphy is a trait or character shared by sister
taxa of a clade that was derived from a previous com-
mon ancestor but not shared by taxa from another
clade. Thus, synapomorphies contribute to the topology
of a phylogenetic tree as factors in defining nodes on
the tree [41]. Using the TNT program we collected
synapomorphies present at each node of the consensus
amino acid tree and examined the frequency of synapo-
morphy for each character across the sequence matrix.
High frequencies of synapomorphy indicate residue
changes at a given position make large contributions to
the topology of the phylogenetic tree (conversely, low
frequencies on the plots are associated with highly con-
served domains/characters present in all terminal taxa
groupings on the tree).
In this study, synapomorphies were first analyzed
across all positions in the dataset (Figure 3) and
then analyses were stratified by the major branches
corresponding to APPL-1, APL-1, AβPP, APLP-2, and
APLP-1 (Figure 4, Tables 1 and 2). The most highly
variable region was the E2 domain, which accounted
for 18.3% of synapomorphies on the whole tree, while
the most highly conserved domain was the E3 domain
(which had 6.9% of the residue synapomorphies). The
E3 region of AβPP, encoded by exons 17 and 18, con-
tributed 1.7% of the synapomorphic frequencies to that
branch and 0.3% for the whole tree. By contrast, the
same region of the other homologues contributed be-
tween 1.2 – 2.4% for the whole tree and 6.3 – 12.5%
for each major branch. The βA4 domain, encoded by
exons 16 and 17, contributed 0.5% and 3.1% of synapo-
morphies to the whole tree and AβPP branch, respect-
ively. The exon 16–17 regions of APLP-1 and APLP-2
contributed 1.5% and 1% of synapomorphies to the
whole tree, respectively, and 8.8% and 5.4% to their re-
spective branches. These data showed the E3 region to
be the most highly conserved part of the entire gene
family and conservation of the βA4/E3 region is even
stronger for vertebrate species.
Figure 3 Synapomorphic Character Frequencies for the Amyloid-β Precursor Protein Gene Family. Histogram of synapomorphic frequency
generated for the whole gene family above the aligned amino acid character map. The colors of the character map were arbitrarily assigned by
Mesquite. Lack of a colored line indicates a gap in the aligned sequences. The five major branches of the AβPP phylogenetic tree are indicated to
the left of the map. The histogram is binned at 5 residues and scaled as a percentage.
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potential
Deposition of Aβ has been well documented in mam-
mals; the sequence is generally >95% identical across
mammals and all vertebrates express β- and γ-secretases
[42-44]. The Guinea pig rodent (Cavia porcelus) and the
common hare (Oryctolagus cuniculus) have been shown
to generate Aβ plaques, but neither the Mus musculus
nor Rattus norvegicus rodents naturally produce Aβ
plaques [45-48]. Evidence of Aβ accumulation in othervertebrate species is sparse. Deposition of extracellular
Aβ has only been documented in one member of class
Osteichthyes: Onchyrus sockeye salmon; the sockeye
AβPP gene has not been sequenced [49]. While some
species of birds may generate Aβ plaques or vascular
amyloid deposition, there is no evidence of plaque for-
mation or extracellular deposition in reptiles and am-
phibians despite >90% sequence homology [47,50]. No
natural invertebrate amyloid-β plaques have been docu-
mented. Recently it was shown that the corresponding
Figure 4 Synapomorphic Frequencies Correspond to Conserved Sequences in the Amyloid-β Precursor Protein Gene Family. Histograms
of synapomorphic frequency generated for each major branch of the gene family above the representative schematic for each member and the
amino acid character map. The colors of the character map were arbitrarily assigned by Mesquite. Lack of a colored line indicates a gap in the
aligned sequences. Relevant taxonomic/cladistic classifications are indicated to the left of the maps. (a) APL-1; (b) APPL-1; (c) AbPP; (d) APLP-2;
and (e) APLP-1 histograms are binned at 5 residues and scaled as percentages. Descriptions of the schematic regions are found in Figure 1.
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when co-expressed at high levels with the endogenous
β-secretase gene [34].
In order to determine when Aβ formation first arose
in evolution, we modeled β-sheet aggregation and amyl-
oid formation probabilities for sequences corresponding
to the human βA4 region using the AmylPred tool and
PASTA server, both of which have been designed and
validated using Aβ [51-54]. We found the C-terminal re-
gion of βA4 domains to have a high probability to form
an amyloid or aggregate for nearly all sequences(Figures 5, 6, and 7). Only sequence from the silkmoth
Bombyx mori had no amyloidogenic potential using both
methods, although AmylPred predicted amyloidogenicity
in a short C-terminal region. Very few sequences with
amyloidogenic potential were found in the N-terminal
region of invertebrate βA4 domains. The cnidarian sea
anemone Nematostella vectensis and hydra Hydra
magnipapillata exhibit strong C-terminal amyloid po-
tential but little potential for amyloid formation in their
N-terminal βA4 (Figure 6a and b). The nematode
Trichinella spiralis is the only worm in our dataset with
Table 1 Synapomorphic frequencies within conserved domains
Domain Whole tree APL-1 APPL-1 AβPP APLP-2 APLP-1
N-Terminal Signal Peptide 11.61 1.25 1.49 2.05 3.31 3.57
E1 14.86 2.71 5.71 3.50 2.43 1.09
E2 18.33 4.95 4.18 3.22 2.83 4.17
E3 6.89 2.44 1.96 0.30 1.19 1.39
APL-1: amyloid precursor like 1 protein; APPL-1: AβPP-like 1 protein; AβPP: amyloid-β precursor protein; APLP-2: amyloid precursor protein like protein 2; APLP-1:
amyloid precursor protein like protein 1. This table shows the percentage of synapomorphy accounted for by the N-terminal signal peptide and the three major
conserved regions of the peptide sequences for the entire phyologenetic tree and the relative contribution for the five major branches.
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dicted by both methods (Figure 6d). The Neohelice
granulata crab has a short N-terminal amyloid prone re-
gion (Figure 6e), but the water flea Daphnia pulex does
not (Figure 6f ). The Drosophila flies all express a
potentially amyloidogenic N-terminal sequence pre-
dicted by AmylPred but with a PASTA energy of – 3.01
(Figure 6g), but no other members of Hymenoptera ex-
press amyloid prone sequence at the N-terminus. The
squid Loligo pealei has PASTA energies < − 4 for long
stretches of the N-terminal βA4 region but no consensus
support from AmylPred (Figure 6i). The sea slug Aplysia
californica has a short region with probable amyloid
forming potential supported by AmylPred and with a
PASTA energy of – 3.16 (Figure 6j). The sea urchins
Stronglyocentrotus purpuratus and Paracentrotus lividus
also had a short N-terminal region predicted to form
amyloid (Figure 6k). The cephalochordate lancelet
Branchiostoma floridae had two long N-terminal regions
with high amyloidogenic potential (Figure 6l). All
AβPP sequences in the dataset exhibited a strongly
amyloidogenic N-terminal region, though the rodent M
musculus and R novergicus sequences had reduced PASTA
energies compared to other vertebrates for their N-
terminal regions (Figures 5 and 7). Interestingly, Danio
rerio APLP2 showed an N-terminal amyloidogenic region
(Figure 7e) while all other APLP2 sequences were identical
at these residues and had a lower probability of forming an
amyloid (Figure 7f). The APLP1 sequences for Xenopus
laevis and Monodelphis domestica showed long sections ofTable 2 Synapomorphic frequencies of domains within
each branch
Domain APL-1 APPL-1 AβPP APLP-2 APLP-1
N-Terminal Signal Peptide 6.41 4.80 11.74 18.47 21.38
E1 13.91 18.36 20.07 13.56 6.54
E2 25.38 13.42 18.49 15.81 24.94
E3 12.50 6.30 1.70 6.63 8.31
APL-1: amyloid precursor like 1 protein; APPL-1: AβPP-like 1 protein; AβPP:
amyloid-β precursor protein; APLP-2: amyloid precursor protein like protein 2;
APLP-1: amyloid precursor protein like protein 1. This table shows the
percentage of synapomorphy accounted for by the N-terminal signal peptide
and the three major conserved regions of the peptide sequences within each
branch of the phylogenetic trees.aggregation prone sequence (Figure 7g and h). The
remaining APLP1 sequences, representing only placental
mammals, show a region with lowered probability of aggre-
gation or fibril formation (Figure 7i).
Discussion
This study provides the most comprehensive phylogeny
of the AβPP gene family based on available data to date.
The analysis reveals that the ancestral sequence evolved
during metazoic divergence, which is much earlier than
previously thought. The results further suggest that
AβPP itself was the first vertebrate sequence and that
APLP-1 and 2 are likely derived from gene duplication
of AβPP.
It is possible that the vertebrate gene family arose as a
duplication of APLP-1 followed by a second duplication
to form APLP-2 and AβPP. However, it is also possible
that the original duplication gave rise to APLP-2 and
AβPP after which a duplication of APLP-2 gave rise to
APLP-1. The search strategy used in this study found
APLP-1 sequences only in tetrapods, AβPP in both car-
tilaginous and bony fish, and APLP-2 in one bony fish
and most tetrapods.
We found that the E3 C-terminal region of the protein
is essentially unchanged since the divergence of jawed
vertebrates during the Ordovician period and that
amyloidogenic Aβ was present around this evolutionary
step. Its persistence is likely due to the overlap with the
E3 domain. It has been shown that the E3 domain is
essential for life in mammals and the βA4 domain con-
tains an HD motif with evidence of positive selection,
both of which may explain some of the persistence of
amyloidogenic Aβ in the mammalian genome [30,35].
Our analysis also found evidence of aggregation prone
C-terminal regions in nearly all sequences in the dataset,
which is not surprising as this is part of the transmem-
brane region high in hydrophobic residues, but a stable
β-fold requires two regions within the peptide. Se-
quences with two separate domains capable of forming
and stabilizing an amyloid were rare in protostomes,
suggesting the characteristic developed after the diver-
gence of deuterostomes and protostomes or was subse-
quently lost through mutation (Figure 8). Of particular
note, the Drosophila sequence is predicted to form an
Figure 5 (See legend on next page.)
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(See figure on previous page.)
Figure 5 Amyloidogenic Potential in the Amyloid-β Sequence. Aligned representative amino acid sequences for the regions corresponding
to exons 16 – 17 of human AβPP. Sequences tested are marked with boxes. Residues with AmylPred consensus and PASTA energies < − 4 are in
red; residues with AmylPred consensus and PASTA energies between – 3 and – 4 are in blue. Known secretase cleavage sites are marked
by arrows.
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Aβ and there is experimental evidence that it can form
fibrillar Aβ in vivo [34]. As no other Hymenoptera spe-
cies in the study show amyloid potential, this likely rep-
resents a new mutation in the development of the
fruitfly species. Interestingly, non-vertebrate deutero-
stome species in this study have amyloidogenic sequence
but little homology to the mammalian Aβ sequence,
suggesting that early amyloid prone regions may have
evolved prior to the divergence of echinoderms, hemi-
chordate, and chordate species. The main sequence vari-
ations arise from the N-terminal region aligned to Homo
sapiens AβPP exon 16. APLP-2 from the zebrafish Danio
rerio also showed amyloidogenic potential and all other
APLP-2 had reduced potential to form Aβ. This is may
be a result of mutation or indels in the exon 16 region
during or after the gene duplication events giving rise to
APLP-1 and APLP-2.
Because the data used in this study were based on in
silico search strategies from deposited sequences in pub-
lic repositories (GenBank and GenPept), it cannot be as-
sumed that these data are necessarily complete for each
species (i.e., a de novo sequencing was not performed for
each species studied). Nonetheless, these data support
the hypotheses that AβPP is the ancestral sequence for
vertebrates, gene duplication after the speciation of car-
tilaginous and bony fish gave rise to APLP-2, and a sub-
sequent partial or degenerate duplication of APLP-2
following the speciation of tetrapods gave rise to APLP-
1. Some species may have subsequently lost either
APLP-1 or APLP-2 genes.
The sequence difference in Mus musculus and Rattus
norvegicus results from three amino acid substitutions
from three single nucleotide changes. Whether the lack
of amyloidogenesis in these particular rodents comes
from these three changes or from other physiological
considerations is unclear, but the presence of identical
sequence in other rodents and mammals in general sug-
gests that the ancestral species to mice and rats evolved
around amyloidogenic Aβ. The lack of data on Aβ de-
position in fish, birds, reptiles, and amphibians also sug-
gests unknown physiological adaptations may limit Aβ
production or deposition. Recently a mutation encoding
a change from alanine to threonine at position 673 of
AβPP was found to be protective against developing
Alzheimer Disease, likely through reduction of β-
secretase processing at that site [10]. It is interesting tonote that all fish sequences in this study, with the excep-
tion of Danio rerio, have a threonine at this position,
suggesting β-secretase processing may be reduced in
these animals. In addition to processes that may increase
or decrease Aβ production by regulating secretase effi-
ciency or transcription, the presence of a β-secretase in
the gene repertoire is an important consideration.
A whole genome assembly for Nematostella vectensis in-
dicate the presence of the secretases but no studies have
examined amyloid formation [55]. A genome for Hydra
magnipapillata predicted the presence of a γ-secretase, but
not a β-secretase (REFSEQ NW_002165109). Experimental
evidence suggests that the nematode Caenorhabditis
elegans does not express a β-secretase, although both α-
and γ-secretases have been identified [56]. A search of
Entrez Nucleotide returned no β-secretase sequences for
other nematodes, crustaceans, hymenoptera, or lepidoptera
in our dataset.
The increased understanding of disease genetics and
increasing availability of molecular sequence data pro-
vide an opportunity to harness evolutionary approaches
to provide deep insights pertaining to the etiology of dis-
ease. Using this approach we found the AβPP family to
have origins in the speciation of the metazoic lineage
and propose that ancestral Aβ may have arisen as
deuterostomia and protostomia diverged. However, other
mutations may continue to produce amyloidogenic se-
quences in this domain, as seen with Drosophila or
unknown physiological factors may play a role in
preventing Aβ formation as in mice and rats. The ap-
proach developed here may be widely applicable to the
study of other critical disease genes and builds a founda-
tion for further studies on the co-evolution of Alzheimer
Disease associated proteins (e.g., co-evolution of ApoE
or β-secretase with AβPP) that may yield novel ap-
proaches to treating or preventing Aβ formation.
Methods
Dataset collection and alignment
Amino acid sequences were collected through Entrez Pro-
tein using a combination of search terms and sequence
similarity searches. First, based on previous studies of se-
quences from the Amyloid-β Precursor Protein [2-4,36]
family five sets of metadata-based search terms developed
and used to identify those sequences from across the
Amyloid-β Precursor Protein family: (1) "App"[gene
name] AND "animals"[porgn:__txid33208];
Figure 6 Amyloid Potential in Invertebrate Amyloid-β Sequence. Plots of probability of aggregation and stabilization of β-fibrils for each
amino acid residue from PASTA for representative species. (a) Hydra magnipapillata, (b) Nematostella vectensis, (c) Caenorhabditis elegans,
(d) Trichinella spiralis, (e) Neohelice granulata, (f) Daphnia pulex, (g) Drosophila melanogaster, (h) Aedes aegypti, (i) Loligo pealei, (j) Aplysia californica,
(k) Stronglyocentrotus pupuratus, and (l) Branchiostoma floridae. Residues with PASTA energies < − 4 and AmylPred consensus are marked with a
black line; residues with PASTA energies between – 3 and – 4 and AmylPred consensus are marked with a grey line.
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Figure 7 Amyloid Potential in Vertebrate Amyloid-β Sequence. Plots of probability of aggregation and stabilization of β-fibrils for each
amino acid residue from PASTA for representative species. (a) Narke japonica AβPP, (b) Danio rerio AβPP, (c) Homo sapiens AβPP, (d) Mus musculus
AβPP, (e) Danio rerio APLP2, (f) Homo sapiens APLP2, (g) Xenopus laevis APLP1, (h) Monodelphis domestica APLP1, and (i) Homo sapiens APLP1.
Residues with PASTA energies < − 4 and AmylPred consensus are marked with a black line; residues with PASTA energies between – 3 and – 4
and AmylPred consensus are marked with a grey line.
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http://www.biomedcentral.com/1471-2164/14/290(2) "aplp1"[gene name] and "animals"
[porgn:__txid33208] ; (3) "aplp2"[gene
name] and "animals"[porgn:__txid33208];
(4) "apl-1"[gene name] and "nematodes"
[porgn:__txid6231]; and (5) "app_amyloid". Se-
quences for which the organism was either “Unknown” or
listed as a “synthetic construct” were removed. Next, a
stringent (E-value = 0.0) blastp (BLAST+ v.2.2.26) was used
to search Entrez Protein for potential orthologous amino
acid sequences for each of the sequences identified in the
metadata-based search from the non-redundant proteindatabase. An additional stringent blastp search was then
done iteratively for each new sequence identified, until no
additional sequences were found. The resulting dataset
(which contained 435 sequences) was then subjected to
multiple sequence alignment using MUSCLE v.3.8.31 [38].
The multiple sequence alignment was manually inspected
(by viewing the data in Mesquite 2.75 [37]) to identify the
one longest representative sequence per taxon (e.g., only
the sequence for human AβPP770 which contains all tran-
scribed and translated exons was kept). As sequences were
removed from the dataset, the multiple sequence alignment
Figure 8 (See legend on next page.)
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(See figure on previous page.)
Figure 8 Evolutionary Relationship of Amyloid-β Formation Potential. Phylogram of the protein sequence for the AβPP family color-coded
by prediction of Amyloid-β formation. Red: High potential (PASTA energies < − 4 and AmylPred consensus); Blue: Low potential (PASTA energies
between – 3 and – 4 and AmylPred consensus); Black: No potential. Species with unique sequences demonstrating potential for Amyloid-β
formation are labeled.
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http://www.biomedcentral.com/1471-2164/14/290was redone. The resulting dataset reflected 103 taxa corre-
sponding to 67 species. Based on identifiers within GenPept
records, corresponding nucleic acid sequences were then
collected for each amino acid sequence. These nucleotide
sequences were also subjected to multiple sequence align-
ment using MUSCLE. Character maps were generated
using the Mesquite character matrices.Generation of phylogenetic trees
Trees were obtained by maximum parsimony using
TNT 1.1 and Bayesian inference using MrBayes 3.2.0
[39,40]. For analyses in TNT, the ‘aquickie.run’ script
was used to guide the search, which aimed to find
the optimal score 20 times independently, using de-
faults of "xmult" plus 10 cycles of tree-drifting. This
resulted in 131 nucleotide trees from more than
8x108 rearrangements and 103714 amino acid trees
from more than 7x108 rearrangements. For consensus
tree calculation, trees were TBR-collapsed, Bremer
group supports calculated by TBR-swapping, and
bootstrap resampling by 100 replications of symmetric
resampling with a single random addition (see Additional
file 1).
For MrBayes, the Metropolis-coupled Markov chain
Monte Carlo analysis was set for 2 runs with 4 chains
each with a temperature of 0.2 degrees. A General
Time Reversible (GTR) model with a Dirichlet (flat)
probability distribution of nucleotide rate change pa-
rameters, stationary nucleotide frequencies, no specified
shape parameter for the gamma distribution of rate
variation, and no invariable sites was used for the nu-
cleotide analyses; this is the default prior model for nu-
cleotide matrices in MrBayes. All runs favored the
WAG rate matrix as the prior model for the amino
acid analyses [57].
Markov Chain analysis was continued until the runs
converged, when the standard deviation of the split
frequencies remained <0.01 and likelihood analysis
found the potential scale reduction factor approached
1.0 [58]. For the nucleotide modeling this took more
than 3x106 generations; for the protein analysis this
took more than 2x106 generations. Consensus trees
were constructed using the 50% majority rule with
95% cumulative posterior probability from 925 nucleo-
tide trees and 1,591 amino acid trees (see Additionalfile 1). All tree diagrams were generated in either
Dendroscope 3.1.0 or FigTree 1.3.1 [59,60].Synapomorphic frequencies
Unambiguous synapomorphies at each node were
generated in TNT for the maximum parsimony con-
sensus trees. The frequency of a given character being
synapomorphic at a given node was examined for the
entire amino acid tree and for each of the five major
branches. Probabilistic models of synapomorphy have
been developed to address the confounding of homo-
plasy and lend statistical support to defining a charac-
ter as synapomorphic as opposed to homoplasious
[41]. While these are important considerations for
higher resolution analysis of a gene family, use of sim-
ple statistical analysis for such a large and diverse
dataset is a reasonable approach to defining areas of
conservation or change, accepting internal error for
random mutation producing homoplasy or loss of an
actual synapomorphy.Aggregation modeling
There are a number of programs available for model-
ing β-folding and aggregation of amyloidogenic pep-
tides [61]. AmylPred is a consensus tool that predicts
β-folding and aggregation based on a set of five pub-
lished methods and uses agreement of 2 or more
methods for determining consensus [54]. PASTA pre-
dicts stabilizing sequences in β-fibrillar structures using
a calculation of the change of energy from pairing be-
tween amino acid sequences [53]. Regions that are
known to form ordered β-fibril structures have a
PASTA energy less than – 4. Using aligned amino acid
sequences coded by Homo sapiens AβPP exons 16 and
17, we examined the corresponding βA4 region across
all taxa and used known secretase cleavage sites to de-
termine the aligned sequences for submission to
AmylPred and PASTA [62-64]. Where cleavage sites
are not known from previous studies, boundaries were
chosen based on similar species and sequences. In
cases where there was no clear similarity, boundaries
were extended to correspond with Homo sapiens
Aβ42. PASTA energies were collected until greater
than – 2 by sequential truncation of the C-terminus
for each sequence.
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Additional file 1: Figure S1. Phylogenetic Relationships among the
Amyloid-β Precursor Protein Gene Family from Baysian Inference. a,
Phylogram showing the evolutionary relationships among the nucleotide
sequences of the AβPP gene family. b, Phylogram for the corresponding
protein sequences. Trees were generated by Bayesian inference methods
and show posterior probability values are each node. Figure S2. Branch
Supports for Phylogenetic Trees. Symmetric bootstrap re-sampling and
Bremer supports, for nucleotide trees (a and b, respectively) and for
amino acid trees (c and d, respectively). Table S1. Taxa Species Names
and Sequence Accession Numbers.
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